Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
BING NEWS:
  • Vivus: A Speculative Play Just Got A Little More Speculative
    The company was never able to partner that drug and subsequent to its launch saw generic applications filed with the FDA for Stendra ... If the company wins its lawsuits, it would have a much better chance at negotiating its debt. A major debt holder ...
    06/22/2016 - 1:13 am | View Link
  • Instant pleasure: Vivus ED pill wins faster-acting 'on demand' label
    The FDA on Thursday approved a revised label for Vivus' erectile dysfunction pill Stendra. Auxilium, which won marketing rights to Stendra in a deal that could be worth as much as $300 million, can now market the drug for use 15 minutes before sex rather ...
    09/17/2014 - 1:00 pm | View Link
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:32 pm | View Link
  • Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges
    Competitor Orexigen Therapeutics Inc. also rose after the Food and Drug Administration advisers voted 20-2 yesterday that Qnexa’s benefits outweigh its risks. While the FDA isn’t required to follow the panel’s recommendation, it often does.
    02/23/2012 - 3:22 am | View Link
  • CORRECTED-Vivus' weight-loss drug faces key U.S. test
    If Qnexa wins the FDA's green light, that could more than double. Analysts estimate Vivus' drug could take in nearly $689 million in sales by 2014, according to consensus forecast data from Thomson Reuters. It would be the second U.S. drug for the biotech ...
    07/15/2010 - 1:11 am | View Link
  • More
BING SEARCH:
  • VIVUS, Inc.
    FDA Advisory Committee Recommends Approval of Qnexa ... VIVUS will hold a conference ... but are not limited to, the response from the United States Food and Drug ...
    08/24/2016 - 7:31 am | View Website
  • VIVUS, Inc.
    Vivus Announces FDA Approval Of STENDRA™ ... (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration ... or call 1-800-FDA-1088. About VIVUS.
    08/22/2016 - 9:30 pm | View Website
  • Vivus
    VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health.
    08/22/2016 - 10:46 am | View Website
  • VIVUS, Inc.
    VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health.
    08/22/2016 - 4:48 am | View Website
  • Products
    VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health.
    08/21/2016 - 4:52 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News